Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ADU-S100 (MIW815) disodium salt is an activator of stimulator of interferon genes (STING).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | 待询 | 5日内发货 | ||
50 mg | 待询 | 5日内发货 | ||
100 mg | 待询 | 5日内发货 |
ADU-S100 disodium salt 的其他形式现货产品:
产品描述 | ADU-S100 (MIW815) disodium salt is an activator of stimulator of interferon genes (STING). |
体外活性 | ADU-S100 shows enhanced type I IFN production over CDA in THP-1 human monocytes. ADU-S100 induces the highest expression of IFN-β and the pro-inflammatory cytokines TNF-α, IL-6, and MCP-1 on a molar equivalent basis, as compared to endogenous ML cGAMP and the TLR3 agonist poly I:C. ADU-S100 is also found to induce aggregation of STING and induce phosphorylation of TBK1 and IRF3 in mouse bone marrow macrophage (BMM). ADU-S100 induces significantly higher levels of IFN-α when compared to ML cGAMP. |
体内活性 | ADU-S100 shows higher anti-tumor control than the endogenous ML cGAMP. A dose-response of the ADU-S100 compound is performed in B16 tumor-bearing mice, which identifies an optimal antitumor dose level that also elicits maximum tumor antigen-specific CD8+ T cell responses, and improves long-term survival to 50%. |
细胞实验 | Cryopreserved hPBMCs are thawed and 1×10^6 cells per well are plated in a 96 well plate in RPMI media supplemented with 10% FBS, 1% non-essential amino acids, 1% penicillin/streptomycin, L-glutamine, 10 mM HEPES buffer, 1 mM Sodium Pyruvate, 0.055 mM β-ME at 37°C with 5% CO2. Cells are stimulated with 10 μM ADU-S100 or ML cGAMP for 6 hours and supernatants are harvested. Supernatants are diluted 1:2 and assayed for IFN-α protein using Cytometric Bead Array (CBA) Human Flex Set. Data is collected using a FACSVerse cytometer. |
动物实验 | WT C57BL/6 mice are inoculated with 5×10^4 B16.F10 cells in the left flank (n=8). When tumor volumes are 100 mm3 mice receive three IT doses of either ML RR-S2 CDG (25 μg), ADU-S100 (50 μg), or HBSS as control. WT C57BL/6 mice are inoculated with 5×10^4 B16.F10 cells in the left flank (n=5). When tumor volumes are 100 mm3 they received three IT doses of ADU-S100 at 5, 25, 50, or 100 μg or HBSS as control. WT C57BL/6 mice are inoculated with 5×104 B16.F10 cells in the left flank (n=8). When tumor volumes are 100 mm3 they receive three IT doses of 100 μg ADU-S100 or HBSS as control. Treatments are administered on days 13, 17, and 20 and tumor measurements are taken twice weekly. Results are shown as percent survival by Log-rank (Mantel-Cox) test (A and C). |
别名 | ML RR-S2 CDA disodium salt, MIW815 disodium salt |
分子量 | 736.52 |
分子式 | C20H24N10Na2O10P2S2 |
CAS No. | 1638750-95-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 300 mg/mL (408.44 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 1.3577 mL | 6.7887 mL | 13.5774 mL | 33.9434 mL |
5 mM | 0.2715 mL | 1.3577 mL | 2.7155 mL | 6.7887 mL | |
10 mM | 0.1358 mL | 0.6789 mL | 1.3577 mL | 3.3943 mL | |
20 mM | 0.0679 mL | 0.3394 mL | 0.6789 mL | 1.6972 mL | |
50 mM | 0.0272 mL | 0.1358 mL | 0.2715 mL | 0.6789 mL | |
100 mM | 0.0136 mL | 0.0679 mL | 0.1358 mL | 0.3394 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
ADU-S100 disodium salt 1638750-95-4 Others ADU-S 100 ML RR-S2 CDA MIW 815 ML RR-S2 CDA disodium salt ADU-S100 ADUS100 disodium salt MIW815 MIW815 disodium ADU S100 disodium salt ADU-S100 disodium ADU-S-100 disodium salt MIW815 disodium salt ML RR-S2 CDA disodium MIW-815 ADU-S-100 Inhibitor inhibitor inhibit